Ireland· IE-PA-EU/1/11/682/001
Methylthioninium chloride Proveblue 5 mg/ml solution for injection
A methylthioninium chloride product containing methylthioninium chloride, registered in Ireland by Provepharm SAS. The same ATC class is registered in 12 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Methylthioninium chloride is registered in 12 of 19 countries.
Countries holding a registration under ATC V03AB17 (methylthioninium chloride), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Methylthioninium chloride · ATC V03AB17
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Methylthioninium chloride
- Manufacturer
- Provepharm SAS
- Country
- Ireland (IE)
- ATC code
- V03AB17
- ATC class
- Methylthioninium chloride
- Defined daily dose
- 0.105 g, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/11/682/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
213 interactions on record for methylthioninium chloride.
Graded by severity as the source publishes them — 141 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methylthioninium chloride · interactions on record
213 records
- 141 severe
- 71 moderate
- 1 minor
Most severe, free to view
- IsomethepteneA03AX10severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Methylthioninium chloride in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMethylene blueSteriscience Specialties Private Limited
- FinlandMethylthioninium Chloride ProvebluePROVEPHARM SAS
- United KingdomMethylthioninium chloride (methylene blue) 100mg/10ml solution for injection ampoulesMartindale Pharmaceuticals Ltd
- BelgiumLumeblue 25 mgCosmo Technologies
- CanadaMETHYLENE BLEU LIQ 1%LABORATOIRE ATLAS INC
- CzechiaMETHYLTHIONINIUMCHLORID PROVEBLUEPROVEPHARM SAS, Marseille
- NorwayMetibloSterop
- SwedenMethylthioninium chloride Proveblue 5 mg/ml Injektionsvätska, lösningProvepharm SAS
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Belgium · Metiblo
- United Kingdom (Northern Ireland) · Methylthioninium Chloride Phebra Limited
- Iceland · Proveblue
- Italy · Metiltioninio Cloruro Bioindustria L.I.M., Metiltioninio Cloruro Monico
- Liechtenstein · Proveblue
- Norway · Proveblue
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/32d6f4f0-3800-4e4a-8ed3-8e4ba482f628 GET /v1/drugs/32d6f4f0-3800-4e4a-8ed3-8e4ba482f628?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"V03AB",
"V03AB17"
],
"strength": null,
"pa_number": "EU/1/11/682/001",
"substances": [
"Methylthioninium chloride"
],
"legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "06/05/2011",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about methylthioninium chloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.